7 June 2022

Case Study: Bridging Anti-CHO Host Cell Protein Antibodies

Bridging Anti-CHO HCP Antibodies from two Cygnus CHO HCP ELISA Kits by AAE-MS™ – This case study presents Ab coverage comparison of polyclonal antibodies supporting the original F550 vs. the resupply F550-1.

Cygnus Technologies has performed an antibody coverage bridging study between the F550 and F550-1 versions of their 3rd generation CHO ELISA kits by Antibody AffinityExtraction (AAE™) with host cell protein (HCP) detection by LC-MS (AAE-MS). The immunoreactivity between F550 and F550-1 antibodies against the CHO master antigen (CMA) HCPs was 97% and 97%, respectively. F550-1 has comparable reactivity to most HCPs such as Phospholipase B Like 2 (PLBL-2), Lysosomal Phospholipase A2 (LPA2), Lipoprotein Lipase (LPL), and Serine protease (HTRA1) and other “problematic” HCPs by fold enrichment, and identical peptides were detected as compared to F550. The F550-1 CHO 3G ELISA kit has equivalent antibody coverage as the F550 kit and is a suitable replacement for the F550 HCP ELISA kit.

Case Study: Bridging Anti-CHO Host Cell Protein Antibodies

Related articles

Newsletter for researchers

We gladly support you by keeping you updated on our latest products and the developments around our services.

we Connect you
Need help? Contact our technical support